EP2637670
Komið í veg fyrir aukaverkanir af völdum sértækra, bindandi CD3 svæða
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
27.10.2011EP published:
8.3.2017EP application number:
11788077.3
EP translation filed:
2.6.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
26.10.2031Expiry date:
26.10.2026Next due date:
31.10.2026
Title:
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
Timeline
Today
27.10.2011EP application
8.3.2017EP Publication
2.6.2017Translation submitted
15.6.2017Registration published
26.10.2026Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477, München, DE
Inventor
Name:
ZUGMAIER, GerhardAddress:
Muenchen, DE
Name:
NAGORSEN, DirkAddress:
Muenchen, DE
Name:
SCHEELE, JuergenAddress:
Muenchen, DE
Agent
Name:
KIPA ABAddress:
Pósthólf 1065, Drottninggatan 11, SE
Priority
Number:
412229 PDate:
10.11.2010Country:
US
Classification
Categories:
A61K 31/573, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 11.9.2017
Expires: 26.10.2018
Payer: Árnason Faktor
Number: 8
Paid: 6.9.2018
Expires: 26.10.2019
Payer: Árnason Faktor
Number: 9
Paid: 9.9.2019
Expires: 26.10.2020
Payer: Árnason Faktor
Number: 10
Paid: 9.9.2020
Expires: 26.10.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.9.2021
Expires: 26.10.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.9.2022
Expires: 26.10.2023
Payer: Patice ehf.
Number: 13
Paid: 6.10.2023
Expires: 26.10.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.9.2024
Expires: 26.10.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 16.10.2025
Expires: 26.10.2026
Payer: Árnason Faktor ehf.